ProQR Therapeutics NV (PRQR)
1.63
-0.02
(-1.21%)
USD |
NASDAQ |
Oct 07, 15:02
ProQR Therapeutics Profit Margin (Quarterly) : -99.65% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -99.65% |
| March 31, 2026 | -658.3% |
| December 31, 2025 | -190.3% |
| September 30, 2025 | -381.9% |
| June 30, 2025 | -319.1% |
| March 31, 2025 | -223.0% |
| December 31, 2024 | -216.0% |
| September 30, 2024 | -211.0% |
| June 30, 2024 | -42.70% |
| March 31, 2024 | -172.1% |
| December 31, 2023 | -167.0% |
| Date | Value |
|---|---|
| September 30, 2023 | -395.6% |
| June 30, 2023 | -662.0% |
| March 31, 2023 | -1.35K% |
| December 31, 2022 | -1.85K% |
| September 30, 2022 | -2.86K% |
| June 30, 2022 | -1.43K% |
| March 31, 2022 | -1.17K% |
| December 31, 2021 | -7.63K% |
| September 30, 2021 | -1.73K% |
| June 30, 2021 | -6.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pharming Group NV | 1.77% |
| NewAmsterdam Pharma Co. NV | -1.73K% |
| argenx SE | -- |
| Mirum Pharmaceuticals, Inc. | -38.14% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -72.59% |
| Return on Assets | -34.70% |
| Return on Invested Capital | -58.40% |
| Gross Profit Margin (Quarterly) | 91.93% |
| Operating Margin (Quarterly) | -100.7% |
| Return on Net Operating Assets | -264.9% |